サインイン

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.

Such synergistic combinations of antibiotics help reduce the minimum inhibitory concentration (MIC) of each by four-fold or more. Synergistic combinations of antibiotics are useful when an infectious agent is unknown or when pathogens have populations of varying drug sensitivity, such as Mycobacterium tuberculosis.

Combining trimethoprim and sulfamethoxazole represents one of the most effective treatments for urinary tract infections. This combination works by inhibiting the activity of two different enzymes involved in the folate pathway, which block the synthesis of purines, the building blocks of DNA. The unavailability of purines impedes DNA synthesis, which ultimately kills the bacteria. Other antibiotic combinations use cell wall-active drugs, such as penicillins, which enhance the permeability of drugs, combined with aminoglycosides, which act on intracellular targets, like 30S ribosomes. These combinations prove highly effective in treating such infections as bacterial endocarditis caused by Enterococcal endocarditis.

In addition, some drugs do not have their own effects but potentiate the effect of other drugs in combination. One useful interaction is between β-lactamase inhibitors such as clavulanic acid and β-lactamase susceptible penicillins. Antibiotics such as penicillins and cephalosporins have β-lactam rings. The bacterial β-lactamase enzyme hydrolyses these rings, making these drugs inactive and leading to the emergence of antibiotic resistance. Using β-lactamase inhibitors and such antibiotics helps overcome the resistance that these bacterial enzymes generate.

タグ
SynergismSupra additive InteractionsTherapeutic EffectDrug CombinationsMinimum Inhibitory Concentration MICTrimethoprimSulfamethoxazoleUrinary Tract InfectionsFolate PathwayDNA SynthesisPenicillinsAminoglycosidesBacterial EndocarditisClavulanic AcidAntibiotic Resistance

章から 4:

article

Now Playing

4.15 : Combined Effects of Drugs: Synergism

薬力学

3.0K 閲覧数

article

4.1 : 薬物作用の原則

薬力学

5.4K 閲覧数

article

4.2 : 薬物作用の標的:概要

薬力学

5.2K 閲覧数

article

4.3 : シグナル伝達:概要

薬力学

8.0K 閲覧数

article

4.4 : トランスデューサーメカニズム:Gタンパク質共役受容体

薬力学

1.6K 閲覧数

article

4.5 : リガンド依存性イオンチャネル受容体:ゲーティング機構

薬力学

1.9K 閲覧数

article

4.6 : トランスデューサーメカニズム:酵素結合受容体

薬力学

2.2K 閲覧数

article

4.7 : トランスデューサーメカニズム:核内受容体

薬力学

1.2K 閲覧数

article

4.8 : 用量反応関係:概要

薬力学

2.7K 閲覧数

article

4.9 : 用量反応関係:効力と効能

薬力学

3.9K 閲覧数

article

4.10 : 用量反応関係:選択性と特異性

薬力学

6.1K 閲覧数

article

4.11 : 治療指数

薬力学

3.8K 閲覧数

article

4.12 : 薬物-受容体相互作用:アゴニスト

薬力学

2.2K 閲覧数

article

4.13 : 薬物-受容体相互作用:アンタゴニスト

薬力学

2.4K 閲覧数

article

4.14 : 薬物の複合効果:拮抗作用

薬力学

7.5K 閲覧数

See More

JoVE Logo

個人情報保護方針

利用規約

一般データ保護規則

研究

教育

JoVEについて

Copyright © 2023 MyJoVE Corporation. All rights reserved